Dr. Ron Weinberger is the Former Exec Director and CEO of Nanosonics' (ASX: NAN), an $800 million market cap healthcare company. He has over 20-years’ experience developing and commercializing medical devices. During his time at Nanosonics, Dr. Weinberger co-developed the company’s platform technology, launched their breakthrough product ‘Trophon’ globally and created a North American sales team to work alongside GE healthcare. He was instrumental in transforming Nanosonics from a research and development company to one of Australia’s leading medical device commercialization success stories.
Dr. Ron Weinberger
Chief Executive Officer